COVID-19: Current Challenges and Future Perspectives
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each...
Saved in:
Other Authors: | , , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_81066 | ||
005 | 20220506 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220506s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-3119-9 | ||
020 | |a 9783036531182 | ||
020 | |a 9783036531199 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-3119-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MMR |2 bicssc | |
100 | 1 | |a Leggat, Peter |4 edt | |
700 | 1 | |a Frean, John |4 edt | |
700 | 1 | |a Blumberg, Lucille |4 edt | |
700 | 1 | |a Leggat, Peter |4 oth | |
700 | 1 | |a Frean, John |4 oth | |
700 | 1 | |a Blumberg, Lucille |4 oth | |
245 | 1 | 0 | |a COVID-19: Current Challenges and Future Perspectives |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (264 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures). | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Environmental medicine |2 bicssc | |
653 | |a COVID-19 | ||
653 | |a SARS-CoV-2 | ||
653 | |a hepatitis B and C | ||
653 | |a cirrhosis | ||
653 | |a chronic kidney disease | ||
653 | |a alcohol-related liver disease | ||
653 | |a nonalcoholic steatohepatitis | ||
653 | |a necrosis | ||
653 | |a MDR-TB | ||
653 | |a clinical trials | ||
653 | |a IL-6 inhibitors | ||
653 | |a tocilizumab | ||
653 | |a cytokine release syndrome | ||
653 | |a cytokine storm | ||
653 | |a operational research | ||
653 | |a health systems | ||
653 | |a SORT IT | ||
653 | |a pandemics | ||
653 | |a training | ||
653 | |a pandemic | ||
653 | |a endemic | ||
653 | |a tuberculosis | ||
653 | |a impact | ||
653 | |a control | ||
653 | |a overview | ||
653 | |a malaria | ||
653 | |a preparedness | ||
653 | |a Africa | ||
653 | |a emergency | ||
653 | |a fecal calprotectin | ||
653 | |a bowel perforation | ||
653 | |a D-Dimer | ||
653 | |a thrombosis | ||
653 | |a ischemia | ||
653 | |a efficacy | ||
653 | |a safety | ||
653 | |a kaletra | ||
653 | |a lopinavir/ritonavir | ||
653 | |a meta-analysis | ||
653 | |a coronavirus | ||
653 | |a SARS-CoV-1 | ||
653 | |a MERS | ||
653 | |a SARS | ||
653 | |a influenza | ||
653 | |a healthcare worker | ||
653 | |a healthcare personnel | ||
653 | |a general practitioners | ||
653 | |a medical doctor | ||
653 | |a heart transplant | ||
653 | |a CMV | ||
653 | |a Chagas disease | ||
653 | |a infection | ||
653 | |a severity | ||
653 | |a respiratory viruses | ||
653 | |a coinfections | ||
653 | |a health care workers | ||
653 | |a Philippines | ||
653 | |a rhinovirus | ||
653 | |a severe acute respiratory syndrome coronavirus 2 | ||
653 | |a plasmodium falciparum | ||
653 | |a differential diagnosis | ||
653 | |a cognitive bias | ||
653 | |a diagnostic reasoning | ||
653 | |a recurrence | ||
653 | |a reinfection | ||
653 | |a Bangladesh | ||
653 | |a Kenya | ||
653 | |a Nairobi | ||
653 | |a presumptive tuberculosis | ||
653 | |a TB treatment outcomes | ||
653 | |a HIV | ||
653 | |a antiretroviral therapy | ||
653 | |a EpiCollect5 | ||
653 | |a Malawi | ||
653 | |a Lilongwe | ||
653 | |a Zimbabwe | ||
653 | |a Harare | ||
653 | |a real-time operational research | ||
653 | |a ethics | ||
653 | |a research capacity building | ||
653 | |a India | ||
653 | |a Nepal | ||
653 | |a post-acute COVID-19 syndrome | ||
653 | |a COVID-19 vaccines | ||
653 | |a mortality | ||
653 | |a epidemiology | ||
653 | |a public health | ||
653 | |a healthcare workers | ||
653 | |a attitudes | ||
653 | |a perceptions | ||
653 | |a knowledge | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5094 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/81066 |7 0 |z DOAB: description of the publication |